Status:
RECRUITING
Mechanisms for Organ Dysfunction in Covid-19
Lead Sponsor:
Uppsala University
Conditions:
COVID-19
Organ Dysfunction Syndrome Sepsis
Eligibility:
All Genders
18+ years
Brief Summary
The study aims to investigate organ dysfunction and biomarkers in patients with suspected or verified COVID-19 during intensive care at Uppsala University Hospital.
Detailed Description
Consenting patients with suspected or verified SARS-COV-2 infection, COVID-19, will undergo daily blood, urine and sputum sampling during their stay in intensive care. Data on organ dysfunction will b...
Eligibility Criteria
Inclusion
- Admitted to intensive care
- suspected or verified COVID-19
Exclusion
- Pregnancy or breastfeeding
- Under-age
Key Trial Info
Start Date :
March 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04316884
Start Date
March 12 2020
End Date
December 31 2026
Last Update
May 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uppsala University Hospital
Uppsala, Sweden, 75185